On Monday, October 23rd, Petmed Express (PETS - Free Report) will release its second quarter earnings before the bell. The company is a Zacks Rank 1 (Strong Buy), and have a Value, Growth, and Momentum score of D.
Dave will look at Petmed’s past earnings, take a look at what is currently going on with the company, and give us his thoughts on their upcoming earnings announcement.
Furthermore, Dave will uncover some potential options trades for investors looking to make a play on Petmed Express ahead of earnings.
Petmed Express in Focus
Petmed Express is America's largest pet pharmacy, delivering prescription and non-prescription pet medications and health and nutritional supplements for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet.
Petmed Express is expected to report earnings at $0.29 per share according to the Zacks Consensus Estimate. Last quarter they beat earnings expectations by 12.50%. They reported earnings at $0.45per share, beating their estimate of $0.40. They have an average earnings surprise of 10.78% over the last 4 quarters.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
On Monday, October 23rd, Petmed Express (PETS - Free Report) will release its second quarter earnings before the bell. The company is a Zacks Rank 1 (Strong Buy), and have a Value, Growth, and Momentum score of D.
Dave will look at Petmed’s past earnings, take a look at what is currently going on with the company, and give us his thoughts on their upcoming earnings announcement.
Furthermore, Dave will uncover some potential options trades for investors looking to make a play on Petmed Express ahead of earnings.
Petmed Express in Focus
Petmed Express is America's largest pet pharmacy, delivering prescription and non-prescription pet medications and health and nutritional supplements for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet.
Petmed Express is expected to report earnings at $0.29 per share according to the Zacks Consensus Estimate. Last quarter they beat earnings expectations by 12.50%. They reported earnings at $0.45per share, beating their estimate of $0.40. They have an average earnings surprise of 10.78% over the last 4 quarters.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PETS - FREE